newsfilter
← Latest News
GlobeNewswire·

Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026

MIAMI, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related